Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Th2.rapa Cells in Metastatic Renal Cell Carcinoma
NCT00923845Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2008
- Primary completion
- Jun 2015
- Modality
- Stem Cell Therapies, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus + sirolimus-generated donor Th2 cells in metastatic renal cell carcinoma (mRCC), sponsored by National Cancer Institute. Started Mar 2008; status: completed.
02
Drugs
sirolimus + sirolimus-generated donor Th2 cells
03
Conditions
metastatic renal cell carcinoma (mRCC)
Beyond the preview
Go deeper on NCT00923845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00923845.